United States Drug Delivery Technology Markets

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

Table of Contents

United States Drug Delivery Technology Markets, Executive SummaryIntroduction to Drug Delivery TechnologiesObjectives and PurposeReport Scope and SegmentationReport StructureSummary of Major FindingsTotal Revenues and Revenue Growth RatesPercent Revenues by Product TypePercent Revenues by Disease CategoryAnalysis by Major SegmentCompetitive AnalysisUnited States Drug Delivery Technology Markets, Market Engineering Research MethodologyFrost & Sullivan's Market Engineering Forecasting Methodology for the Healthcare IndustryFrost & Sullivan's Market Engineering Forecasting Methodology for the Healthcare IndustryResearch SourcesSecondary SourcesPrimary ResearchIndustry Specific Forecast ModelIndustry Specific Forecast ModelPopulation-Based ForecastProduct-Based ForecastMarket Model AssumptionsPresentation of Market Engineering Measurements, Definition and their Strategic SignificancePresentation of Market Engineering Measurements, Definition and their Strategic SignificanceUnited States Drug Delivery Technology Markets, Challenges in the Drug Delivery Technologies MarketIdentification of Challenges Facing the Drug Delivery Technologies MarketIdentification of Challenges Facing the Drug Delivery Technologies MarketCompeting with Well Known DrugDelivery Companies to Gain Profitable Corporate CollaborationsExpanding Beyond a Drug Delivery Company to Full Integration with Limited RevenuesMaintaining High Profit Margins in Increasingly Generic MarketsDeveloping Systems Which Do Not Impinge on PatentsDiscovering Novel Therapeutic Areas Which Can Be Addressed by TechnologiesEffectively Marketing Systems with Limited AdvantagesUnited States Drug Delivery Technology Markets, Overview of the Drug Delivery CompaniesIntroductionIntroductionCompany ProfilesMarket Engineering Research for the Oral Drug Delivery Technologies MarketMarket Overview and DefinitionsOverviewTechnology OverviewMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket DriversMarket DriversGrowth in the Discovery of "Biotechnology" Compounds Increases Development of Drug Delivery Products The Drive to Obviate Revenue Loss from Patent Expiration Motivates Alignment with Drug Delivery CompaniesPliability of Delivery Systems Creates Significant Market OpportunitiesBeneficial Safety and Efficacy Profiles Drive Penetration of Delivery ProductsPrice Premium Charged for Products Drives Gross RevenuesImprovements in Technology Decreases Development and Manufacture Cost of some Systems. Market RestraintsMarket RestraintsGeneric Competition Diminishes Manufacturer Revenues and Decreases the value of Key Markets Financial Barriers to Entry Remain Obstacles for Less Established CompetitorsPatent Infringement Limits Market Opportunities Collaborative Partnerships Prevent Greater Revenue Realization by Drug Delivery ManufacturersMarket Engineering Revenue Forecasts (1996-2002)Total RevenuesBreakout of Revenues by Disease CategoryResearch and DevelopmentResearch and DevelopmentActiqDitropan XLCompetitive EnvironmentCompetitive StructureMarket Share AnalysisMarket Share ParticipantsProducts AnalysisProducts AnalysisAlkermes, Inc.Alza CorporationAndrx CorporationAnesta CorporationBiovail CorporationElan CorporationFuisz TechnologiesGenta, Inc.Market Engineering for the Transdermal Drug Delivery Technologies MarketMarket Overview and DefinitionsOverviewTechnology OverviewMarket DriversMarket DriversThe Emergence of Combination Patches for Female Hormone Replacement Therapy Drive Long-Term GrowthPotential to Extend Product LinesMotivates Formation of Profitable PartnershipsAdvantages Drives Penetration of Transdermal Products into Key MarketsSecond Generation Androgen Patches Highlight Disease and Positively Effect Market Revenues Implementation of New Technology has Potential to Drive Market in the Long TermMarket RestraintsMarket RestraintsTechnological Limitations Inhibit Reach of Transdermal Delivery Systems Generic Competition Diminishes Manufacturer Revenues and Decreases the Value of Key Markets Minimal Advantages May Inhibit Greater Product PenetrationCollaborative Partnerships Prevent Greater Revenue Realization by Drug Delivery ManufacturersMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket Engineering Revenue Forecasts (1996-2002)Total RevenuesBreakout of Revenues by Disease CategoryResearch and DevelopmentResearch and DevelopmentCombination Patches for Hormone Replacement TherapyExtended Release RitalinCompetitive EnvironmentCompetitive StructureMarket Share AnalysisMarket Share ParticipantsProduct AnalysisProduct AnalysisAlza CorporationBecton DickinsonCellegy PharmaceuticalsCygnus, Inc.Elan Pharmaceutical TechnologiesIomed, Inc.MacroChem CorporationNoven PharmaceuticalsMarket Engineering Research for the Inhale Drug Delivery Technologies Market Market Overview and DefinitionsOverviewTechnology OverviewMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket DriversMarket DriversGrowth in the Discovery of "Biotechnology" Compounds Increases Development of Drug Delivery Products Pliability of Delivery Systems Creates Significant Market OpportunitiesThe Drive to Generate Revenue Through Line Extensions Creates Profitable Partnerships for Drug Delivery CompaniesAdvantages of Inhale Delivery Systems Expected to Aid Future Penetration into Key MarketsAbility to Deliver Locally and Systemically Increases Market Opportunity Market Restraints Market Restraints Unproved Technology Remains Challenge to Market ParticipantsLaunch of Products Utilizing New Technology not Expected in Short-termManufacturing Costs Decrease Product Profit MarginsCollaborative Partnerships Prevent Greater Revenue Realization by Drug Delivery ManufacturersResearch and DevelopmentResearch and DevelopmentPain ManagementDiabetesCompetitive EnvironmentCompetitive StructureProduct AnalysisProduct AnalysisAradigm CorporationDura PharmaceuticalsInhale TherapeuticsMarket Engineering Research for the Inject Drug Delivery Technologies Market Market Overview and DefinitionsOverviewTechnology OverviewMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket DriversMarket DriversPotential to Extend Product Lines Motivates Formation of Profitable PartnershipsBeneficial Safety and Efficacy Profiles Drive Penetration of Delivery ProductsLimited Competition Increases Market OpportunityGrowth in the Discovery of "Biotechnology" Compounds Increases Development of Drug Delivery Products Price Premium Charged for Products Drives Gross RevenuesMarket RestraintsMarket RestraintsLimited Therapeutic Markets for Which Technology Is ApplicableSaturated Competitive Environmentin the Cancer Therapeutics Creates Fragmented MarketInfancy of Development Pipeline Negatively Impacts Total MarketMarket Engineering Revenue Forecasts (1996-2002)Total RevenuesBreakout of Revenues by Disease CategoryResearch and DevelopmentResearch and DevelopmentPegylated Intron AEvacetCompetitive EnvironmentCompetitive StructureMarket Share AnalysisMarket Share ParticipantsProduct AnalysisProduct AnalysisAlkermes, Inc.DepoTechEnzon, Inc. (PEG-Modification System)Epic TherapeuticsThe Liposome CompanySequus Pharmaceuticals, Inc. United States Drug Delivery Technology Markets, Market Engineering StrategyMarket Engineering Strategic RecommendationsMarket Engineering Strategic RecommendationsStrategies Based on Competitive Corporate PositioningStrategies Based on Research and Development




Related Research

Release Date : 19-Sep-17

Region : North America

Release Date : 08-Sep-17

Region : North America

Release Date : 22-Aug-17

Region : North America

Release Date : 08-Aug-17

Region : North America

Release Date : 31-Jul-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.